Patheon Inc. Adds Capability To Conduct Cell Based Assays

Patheon Inc. , a global provider of drug development and manufacturing services to the international pharmaceutical industry, is pleased to announce the introduction of cell based assay services to support biopharmaceutical product development.

The new services will strengthen Patheon's existing analytical capability in biopharmaceutical analysis. Cell based assays are a key technology used in determining the biological potency of biopharmaceuticals required for product licensing procedures. Biological potency analytics and the required supporting capabilities for tissue culture, such as assessment of cell viability and production of master and working cell banks, will take place at Patheon's Swindon, UK facility. This will enable all the analytical needs for biopharmaceutical product development to be completed in one location.

Wes Wheeler, President and CEO of Patheon Inc. stated, "Expanding the services provided through using cell based assays at our Swindon facility, is a testament to the commitment Patheon has to enhancing and growing the Pharmaceutical Development Services provided to our customers. This new capability allows us to better meet the needs of customers in the early stages of drug development."

The facility will be managed and supported by a team of scientists with approximately 18 years of combined experience in tissue culture and cell based assays. The facility will be fully available for use at the end of May.

About Patheon
Patheon Inc. is a leading global provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to more than 300 of the world's leading pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative technologies including single-use disposables, Liquid-Filled Hard Capsules and a variety of modified release technologies.

Patheon's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon can take customers direct to clinic with global clinical packaging and distribution services and Patheon's Quick to Clinic™ programs can accelerate early phase development project to clinical trials while minimizing the consumption of valuable API. Patheon's integrated network strives to ensure that customer products can be launched with confidence globally. For more information vist www.patheon.com

SOURCE: Patheon Inc.